Cat. No JK227935_1_G
J&K Chemical

Product Information

Product Name
Simvastatin, 97%, inhibitor of HMG-CoA reductase
Brand Name
J&K
Product Number
227935
CAS
79902-63-9
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
54454
IUPAC Name
(1S,3R,7S,8S,8aR)-8-2-(2R,4R)-4-hydroxy-6-oxooxan-2-ylethyl-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
InChI Key
RYMZZMVNJRMUDD-HGQWONQESA-N
SMILES
CCC(C)(C)C(=O)OC@H1CC@H(C=C2C@H1C@H(C@H(C=C2)C)CCC@@H3CC@H(CC(=O)O3)O)C

Safety Information

Storage Condition
Store at 2-8℃

References Data Source From Pubchem

Correction: Endovascular therapy for erectile dysfunction: insights from more than 1000 treatments

Publication Name: CVIR Endovascular
Publication Date: 2026-07-03
DOI: 10.1186/s42155-026-00666-y|10.1186/s42155-026-00723-6

Title Not Available

Publication Name: MMW Fortschritte der Medizin
Publication Date: 2026-06
DOI: 10.1007/s15006-025-4798-6|10.1007/s15006-025-4961-0|10.1007/s15006-025-4986-4|10.1007/s15006-026-5827-9|10.1007/s15006-026-5961-4|10.1007/s15006-026-6004-x|10.1007/s15006-026-6018-4|10.1007/s15006-026-6024-6|10.1007/s15006-026-6091-8

Correction: Vitamin D status and cardiometabolic risk factors among hypertensive and normotensive adults: a hospital-based cross-sectional study in Nepal

Publication Name: BMC Nutrition
Publication Date: 2026-05-20
DOI: 10.1186/s40795-026-01247-x|10.1186/s40795-026-01348-7

Title Not Available

Publication Name: MMW Fortschritte der Medizin
Publication Date: 2026-05
DOI: 10.1007/s15006-024-4570-3|10.1007/s15006-025-4588-1|10.1007/s15006-025-4608-1|10.1007/s15006-025-4622-3|10.1007/s15006-025-4624-1|10.1007/s15006-025-4649-5|10.1007/s15006-025-4710-4|10.1007/s15006-025-4742-9|10.1007/s15006-025-4743-8|10.1007/s15006-025-4831-9|10.1007/s15006-025-4880-0|10.1007/s15006-025-4911-x|10.1007/s15006-025-4938-z|10.1007/s15006-025-5102-5|10.1007/s15006-025-5185-z|10.1007/s15006-025-5186-y|10.1007/s15006-025-5211-1|10.1007/s15006-025-5277-9|10.1007/s15006-025-5444-z|10.1007/s15006-025-5502-6|10.1007/s15006-025-5518-y|10.1007/s15006-026-5646-z|10.1007/s15006-026-5670-z|10.1007/s15006-026-5694-4|10.1007/s15006-026-5697-1|10.1007/s15006-026-5839-5|10.1007/s15006-026-5857-3|10.1007/s15006-026-5858-2|10.1007/s15006-026-5880-4|10.1007/s15006-026-5902-2|10.1007/s15006-026-5903-1|10.1007/s15006-026-5904-0|10.1007/s15006-026-5933-8|10.1007/s15006-026-5956-1

Correction to: Potential for multidrug combination therapy in patients with World Federation of Neurological Surgeons grade V subarachnoid hemorrhage

Publication Name: Neurosurgical Review
Publication Date: 2026-04-28
DOI: 10.1007/s10143-025-03945-9|10.1007/s10143-026-04302-0

Simvastatin, 97%, inhibitor of HMG-CoA reductase

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page